Xeber.world
Axsome Therapeutics has received FDA approval for its Alzheimer’s agitation drug, marking a significant advancement in neurotherapeutic treatments. Th...
The FDA proposed excluding semaglutide and tirzepatide from compounding lists, citing no clinical need. Katherine Szarama was named acting director of...
The FDA has named Katherine Szarama as the acting director of the Center for Biologics Evaluation and Research. She replaces Vinay Prasad, who left th...